Soft-bodied fossils of annelids from the Cambrian are relatively rare but provide vital insights into the early evolution and diversification of annelids. Here we describe a new annelid, gen. et sp. nov., from the early Cambrian (Stage 3) Xiaoshiba biota of Kunming, Yunnan Provence, China. This worm is obliquely oriented in the sediment, and is characteristic of a cephalic cage-like structure formed by the anteriorly directed parapodia and long chaetae of chaetiger 1, strongly suggesting an endobenthic lifestyle. This first report of an annelid worm from the Xiaoshiba biota provides the earliest known plausible evidence of burrowing behaviour in Annelida. Phylogenetic analyses recover in the polytomy with other crown-group Annelida, indicating that the evolution of cephalic cage in Annelida is most likely convergent.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11461068 | PMC |
http://dx.doi.org/10.1098/rsbl.2024.0357 | DOI Listing |
Sci Adv
January 2025
School of GeoSciences, University of Edinburgh, James Hutton Road, Edinburgh EH9 3FE, UK.
Whether metazoan diversification during the Cambrian Radiation was driven by increased marine oxygenation remains highly debated. Repeated global oceanic oxygenation events have been inferred during this interval, but the degree of shallow marine oxygenation and its relationship to biodiversification and clade appearance remain uncertain. To resolve this, we interrogate an interval from ~527 to 519 Ma, encompassing multiple proposed global oceanic oxygenation events.
View Article and Find Full Text PDFData Brief
February 2025
Department of Geological Sciences, University of Saskatchewan, Saskatoon, SK S7N 5E2, Canada.
Extensive ichnologic and sedimentologic datasets were gathered from six localities (Fortune Head, Fortune North, Grand Bank Head, Lewin's Cove, Little Dantzic Cove, and Point May) of the Ediacaran-Cambrian Chapel Island Formation at Burin Peninsula, southeastern Newfoundland, eastern Canada. 1708.2 m of sedimentary strata were logged at a centimeter scale (1:40) using a Jacob staff, in addition to 11.
View Article and Find Full Text PDFACS Omega
January 2025
Hubei Key Laboratory of Petroleum Geochemistry and Environment, College of Resources and Environment, Yangtze University, Wuhan 430100, China.
Recently, significant breakthroughs have been made in the exploration of shale gas in the Lower Cambrian black shale of the Sichuan Basin, indicating a promising commercial extraction potential. However, there remains considerable controversy regarding the pore structural characteristics for this shale formation, especially in the deep-water region. To address this, this paper focused on core samples from two shale gas wells (Xa1 and Xb1) located in the slope-basin facies zone during the Early Cambrian.
View Article and Find Full Text PDFLancet Diabetes Endocrinol
January 2025
British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. Electronic address:
Background: Data on the effect of mineralocorticoid receptor antagonist therapy on HbA levels and new-onset diabetes are conflicting. We aimed to examine the effect of oral finerenone, compared with placebo, on incident diabetes in the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure (FINEARTS-HF) trial.
Methods: In this randomised, double-blind, placebo-controlled trial, 6001 participants with heart failure with New York Heart Association functional class II-IV, left ventricular ejection fraction 40% or higher, evidence of structural heart disease, and elevated N-terminal pro-B-type natriuretic peptide levels were randomly assigned to finerenone or placebo, administered orally.
J Am Coll Cardiol
January 2025
British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address:
Background: An initial decline in estimated glomerular filtration rate (eGFR) often leads to reluctance to continue life-saving therapies in patients with heart failure (HF).
Objectives: The goal of this study was to describe the association between initial decline in eGFR and subsequent clinical outcomes in patients randomized to placebo or finerenone.
Methods: In this prespecified analysis of FINEARTS-HF (Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure), we examined the association between initial decline in eGFR (≥15%) from randomization to 1 month and subsequent outcomes in patients assigned to finerenone or placebo.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!